Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients. Iaffaldano P, Viterbo R G, Trojano M J Neurol. 2016 Jun 3. Epub 2016 Jun 03. PMID: 27260295. Abstract CommentRecommendBookmarkWatch
